A triple-helix forming oligonucleotide targeting genomic DNA fails to induce mutation.
Purine tracts in duplex DNA can bind oligonucleotide strands in a sequence specific manner to form triple-helix structures. Triple-helix forming oligonucleotides (TFOs) targeting supFG1 constructs have previously been shown to be mutagenic raising safety concerns for oligonucleotide-based pharmaceuticals. We have engineered a TFO, TFO27, to target the genomic Hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus to define the mutagenic potential of such structures at genomic DNA. We report that TFO27 was resistant to nuclease degradation and readily binds to its target motif in a cell free system. Contrary to previous studies using the supFG1 reporter construct, TFO27 failed to induce mutation within the genomic HPRT locus. We suggest that it is possible that previous reports of triplex-mediated mutation using the supFG1 reporter construct could be confounded by DNA quadruplex formation. Although the present study indicates that a TFO targeting a genomic locus lacks mutagenic activity, it is unclear if this finding can be generalised to all TFOs and their targets. For the present, we suggest that it is prudent to avoid large purine stretches in oligonucleotide pharmaceutical design to minimise concern regarding off-target genotoxicity.
Biomolecular Medicine, Imperial College, London SW7 2AZ, UK.
Reshat
R
Reshat
Catherine C
CC
Priestley
Nigel J
NJ
Gooderham
D002460:Cell Line; D004247:DNA / Q000737:chemistry / Q000235:genetics*; D004249:DNA Damage; D024202:Electrophoretic Mobility Shift Assay; D018390:Gene Targeting / Q000379:methods*; D056426:Genetic Loci; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009841:Oligonucleotides / Q000235:genetics / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D011687:Purines / Q000737:chemistry*; D017422:Sequence Analysis, DNA
D009841:Oligonucleotides; D011687:Purines; D004247:DNA; D007041:Hypoxanthine Phosphoribosyltransferase